![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 491/147 | (2006.01) |
A61P 19/02 | (2018.01) | ||
C07D 491/048 | (2006.01) | ||
C07D 491/147 | (2013.01) | ||
A61K 31/437 | (2006.01) | ||
C07D 491/048 | (2013.01) | ||
A61P 19/02 | (2006.01) | ||
A61K 31/4155 | (2006.01) | ||
A61K 31/519 | (2006.01) |
(11) | Number of the document | 3509591 |
(13) | Kind of document | T |
(96) | European patent application number | 17858944.6 |
Date of filing the European patent application | 2017-09-30 | |
(97) | Date of publication of the European application | 2019-07-17 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/054668 |
Date | 2017-09-30 |
(87) | Number | WO 2018/067422 |
Date | 2018-04-12 |
(30) | Number | Date | Country code |
201662403660 P | 2016-10-03 | US |
(72) |
LIANG, Congxin , US
|
(73) |
Highlightll Pharmaceutical (Hainan) Co., Ltd. ,
Building A, 5th floor,
Suite A22-21,
Incubator Center of Haikou Hightech
Industrial Development Zone,
Haikou, Hainan, 570000,
CN
|
(54) | NOVEL JAK1 SELECTIVE INHIBITORS AND USES THEREOF |
NOVEL JAK1 SELECTIVE INHIBITORS AND USES THEREOF |